Literature DB >> 25589966

Rapid pleurodesis is an outpatient alternative in patients with malignant pleural effusions: a prospective randomized controlled trial.

Serkan Özkul1, Akif Turna1, Ahmet Demirkaya1, Burcu Aksoy1, Kamil Kaynak1.   

Abstract

BACKGROUND: Chemical pleurodesis can be palliative for recurrent, symptomatic pleural effusions in patients who are not candidate for a thoracic surgical procedure. We hypothesized that effective pleurodesis could be accomplished with a rapid method of pleurodesis as effective as the standard method.
METHODS: A prospective randomized 'non-inferiority' trial was conducted in 96 patients with malignant pleural effusion (MPE) who are not potentially curable and/or not amenable to any other surgical intervention. They were randomly allocated to group 1 (rapid pleurodesis) and to group 2 (standard protocol). In group 1, following complete fluid evacuation, talc slurry was instilled into the pleural space. This was accomplished within 2 h of thoracic catheter insertion, unless the drained fluid was more than 1,500 mL. After clamping the tube for 30 min, the pleural space was drained for 1 h, after which the thoracic catheter was removed. In group 2, talc-slurry was administered when the daily drainage was lower than 300 mL/day.
RESULTS: No-complication developed due to talc-slurry in two groups. Complete or partial response was achieved in 35 (87.5%) and 33 (84.6%) patients in group 1 and group 2 respectively (P=0.670). The mean drainage time was 40.7 and 165.2 h in group 1 and group 2 respectively (P<0.001).
CONCLUSIONS: Rapid pleurodesis with talc slurry is safe and effective and it can be performed in an outpatient basis.

Entities:  

Keywords:  Pleurodesis; malignant pleural effusion (MPE); slurry; talc

Year:  2014        PMID: 25589966      PMCID: PMC4283316          DOI: 10.3978/j.issn.2072-1439.2014.11.31

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  11 in total

Review 1.  Management of malignant pleural effusions.

Authors:  V B Antony; R Loddenkemper; P Astoul; C Boutin; P Goldstraw; J Hott; F Rodriguez Panadero; S A Sahn
Journal:  Eur Respir J       Date:  2001-08       Impact factor: 16.671

2.  BTS guidelines for the management of malignant pleural effusions.

Authors:  G Antunes; E Neville; J Duffy; N Ali
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

Review 3.  Malignant pleural effusions.

Authors:  Joe B Putnam
Journal:  Surg Clin North Am       Date:  2002-08       Impact factor: 2.741

4.  Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion.

Authors:  Carolyn M Dresler; Jemi Olak; James E Herndon; William G Richards; Ernest Scalzetti; Stewart B Fleishman; Kemp H Kernstine; Todd Demmy; David M Jablons; Leslie Kohman; Thomas M Daniel; George B Haasler; David J Sugarbaker
Journal:  Chest       Date:  2005-03       Impact factor: 9.410

Review 5.  Treating malignant pleural effusions cost consciously.

Authors:  C P Belani; T S Pajeau; C L Bennett
Journal:  Chest       Date:  1998-01       Impact factor: 9.410

6.  Rapid pleurodesis for malignant pleural effusions: a pilot study.

Authors:  Chakravarthy Reddy; Armin Ernst; Carla Lamb; David Feller-Kopman
Journal:  Chest       Date:  2010-10-07       Impact factor: 9.410

7.  Rapid pleurodesis for malignant pleural effusions.

Authors:  Peter A Spiegler; Adam N Hurewitz; Maritza L Groth
Journal:  Chest       Date:  2003-06       Impact factor: 9.410

8.  Rapid pleurodesis in symptomatic malignant pleural effusion.

Authors:  Erkan Yildirim; Koray Dural; Rasih Yazkan; Nurullah Zengin; Dilsad Yildirim; Nesimi Gunal; Unal Sakinci
Journal:  Eur J Cardiothorac Surg       Date:  2005-01       Impact factor: 4.191

9.  Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study.

Authors:  Julius P Janssen; Gareth Collier; Phillippe Astoul; Gian Franco Tassi; Marc Noppen; Francisco Rodriguez-Panadero; Robert Loddenkemper; Felix Jf Herth; Stefano Gasparini; Charles H Marquette; Birgit Becke; Marios E Froudarakis; Peter Driesen; Chris T Bolliger; Jean-Marie Tschopp
Journal:  Lancet       Date:  2007-05-05       Impact factor: 79.321

Review 10.  Pleurodesis for malignant pleural effusions: current controversies and variations in practices.

Authors:  Sophie D West; Robert J O Davies; Y C Gary Lee
Journal:  Curr Opin Pulm Med       Date:  2004-07       Impact factor: 3.155

View more
  3 in total

Review 1.  Interventions for the management of malignant pleural effusions: a network meta-analysis.

Authors:  Amelia O Clive; Hayley E Jones; Rahul Bhatnagar; Nancy J Preston; Nick Maskell
Journal:  Cochrane Database Syst Rev       Date:  2016-05-08

2.  Interventions for the management of malignant pleural effusions: a network meta-analysis.

Authors:  Alexandra Dipper; Hayley E Jones; Rahul Bhatnagar; Nancy J Preston; Nick Maskell; Amelia O Clive
Journal:  Cochrane Database Syst Rev       Date:  2020-04-21

3.  Are the MORECare guidelines on reporting of attrition in palliative care research populations appropriate? A systematic review and meta-analysis of randomised controlled trials.

Authors:  Anna Oriani; Lesley Dunleavy; Paul Sharples; Guillermo Perez Algorta; Nancy J Preston
Journal:  BMC Palliat Care       Date:  2020-01-09       Impact factor: 3.234

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.